Amneal Launches Polysorbate-Free Fosaprepitant In The US
The Launch Highlights Amneal’s Continued Interest In Complex Products
Marking the firm’s second launch of a 505(b)(2) injectable this year, Amneal has released Focinvez in the US as an antiemetic agent used in chemotherapy regimens.
